Serum α-melanocyte-stimulating hormone may act as a protective biomarker for non-traumatic osteonecrosis of the femoral head.

MLA

Mao, Zheng, et al. “Serum α-Melanocyte-Stimulating Hormone May Act as a Protective Biomarker for Non-Traumatic Osteonecrosis of the Femoral Head.” Annals of Clinical Biochemistry, vol. 55, no. 4, July 2018, pp. 453–60. EBSCOhost, https://doi.org/10.1177/0004563217738802.

APA

Mao, Z., Liu, G., Chen, J.-J., Liu, D., Xu, M.-P., Zhao, C., Yang, H.-T., & Yue, Y.-B. (2018). Serum α-melanocyte-stimulating hormone may act as a protective biomarker for non-traumatic osteonecrosis of the femoral head. Annals of Clinical Biochemistry, 55(4), 453–460. https://doi.org/10.1177/0004563217738802

Chicago

Mao, Zheng, Gang Liu, Jing-Jie Chen, Dan Liu, Min-Peng Xu, Chang Zhao, Hai-Tao Yang, and Yong-Bin Yue. 2018. “Serum α-Melanocyte-Stimulating Hormone May Act as a Protective Biomarker for Non-Traumatic Osteonecrosis of the Femoral Head.” Annals of Clinical Biochemistry 55 (4): 453–60. doi:10.1177/0004563217738802.